,
your personalized virtual assistant to find clinical trials. Go head, 
Richard C. Frank, MD
Norwalk HospitalNorwalk, Connecticut - 06856 (203-852-2996) |
- CLINICAL TRIALS 11
- CONDITIONS24
- INTERVENTIONS39
- SINCE
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
-
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
May 2009 - December 2012
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
October 2009 - April 2013
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
September 2006 - July 2008
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia
August 2006 - February 2008
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
December 2006 - September 2011
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402
December 2007 - June 2016
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
August 2003 - July 2010
Breast Neoplasms
Colonic Neoplasms
Adenocarcinoma
Prostatic Neoplasms
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Leukemia, Myelomonocytic, Acute
Leukemia, Myelomonocytic, Chronic
Carcinoma, Renal Cell
Carcinoma
Fatigue
Esophageal Diseases
Esophageal Neoplasms
Colorectal Neoplasms
Sleep Disorders
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Placebo
Laboratory Biomarker Analysis
Assessment Of Therapy Complications
Psychosocial Assessment And Care
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Cyclophosphamide
Radiation Therapy
Oxaliplatin
Doxorubicin Hydrochloride
Rad001
Polymerase Chain Reaction
Flow Cytometry
Goserelin
Leuprolide Acetate
Triptorelin
Trastuzumab
Western Blotting
Fluorescence In Situ Hybridization
Conventional Surgery
Azacitidine
Mutation Analysis
Sunitinib
Cetuximab
Cognitive Assessment
Tamoxifen Citrate
Irinotecan Hydrochloride
Fatigue Assessment And Management
Nucleic Acid Sequencing
Ac Regimen
Exemestane
Entinostat
Epirubicin Hydrochloride
Oophorectomy
